249 related articles for article (PubMed ID: 31371521)
21. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
Daun T; Nienhold R; Paasinen-Sohns A; Frank A; Sachs M; Zlobec I; Cathomas G
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359622
[TBL] [Abstract][Full Text] [Related]
22. Exon 9 Mutation of
Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
[TBL] [Abstract][Full Text] [Related]
23. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Han N; Kim MA; Lee HS; Kim WH
Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
[TBL] [Abstract][Full Text] [Related]
24. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
25. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
26. Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications.
Martinez-Ciarpaglini C; Fleitas-Kanonnikoff T; Gambardella V; Llorca M; Mongort C; Mengual R; Nieto G; Navarro L; Huerta M; Rosello S; Roda D; Tarazona N; Navarro S; Ribas G; Cervantes A
ESMO Open; 2019; 4(3):e000470. PubMed ID: 31231566
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
28. EBV and MSI Status in Gastric Cancer: Does It Matter?
do Nascimento CN; Mascarenhas-Lemos L; Silva JR; Marques DS; Gouveia CF; Faria A; Velho S; Garrido R; Maio R; Costa A; Pontes P; Wen X; Gullo I; Cravo M; Carneiro F
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612071
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers.
Chang MS; Lee JH; Kim JP; Kim HS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Int; 2000 Jun; 50(6):486-92. PubMed ID: 10886725
[TBL] [Abstract][Full Text] [Related]
30. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.
Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ
Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938
[TBL] [Abstract][Full Text] [Related]
31. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
32. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Biesma HD; Soeratram TTD; Sikorska K; Caspers IA; van Essen HF; Egthuijsen JMP; Mookhoek A; van Laarhoven HWM; van Berge Henegouwen MI; Nordsmark M; van der Peet DL; Warmerdam FARM; Geenen MM; Loosveld OJL; Portielje JEA; Los M; Heideman DAM; Meershoek-Klein Kranenbarg E; Hartgrink HH; van Sandick J; Verheij M; van de Velde CJH; Cats A; Ylstra B; van Grieken NCT
Gastric Cancer; 2022 May; 25(3):640-651. PubMed ID: 35129727
[TBL] [Abstract][Full Text] [Related]
33. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
34. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
[TBL] [Abstract][Full Text] [Related]
35. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells.
Tsai CY; Liu YY; Liu KH; Hsu JT; Chen TC; Chiu CT; Yeh TS
J Gastroenterol Hepatol; 2017 Jan; 32(1):82-91. PubMed ID: 27144885
[TBL] [Abstract][Full Text] [Related]
37. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
[TBL] [Abstract][Full Text] [Related]
38. Low-frequency microsatellite instability in genomic di-nucleotide sequences correlates with lymphatic invasion and poor prognosis in gastric cancer.
Zhao Y; Zheng ZC; Luo YH; Piao HZ; Zheng GL; Shi JY; Zhang T; Zhang JJ
Cell Biochem Biophys; 2015 Jan; 71(1):235-41. PubMed ID: 25108737
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
Corso S; Isella C; Bellomo SE; Apicella M; Durando S; Migliore C; Ughetto S; D'Errico L; Menegon S; Moya-Rull D; Cargnelutti M; Capelôa T; Conticelli D; Giordano J; Venesio T; Balsamo A; Marchiò C; Degiuli M; Reddavid R; Fumagalli U; De Pascale S; Sgroi G; Rausa E; Baiocchi GL; Molfino S; Pietrantonio F; Morano F; Siena S; Sartore-Bianchi A; Bencivenga M; Mengardo V; Rosati R; Marrelli D; Morgagni P; Rausei S; Pallabazzer G; De Simone M; Ribero D; Marsoni S; Sottile A; Medico E; Cassoni P; Sapino A; Pectasides E; Thorner AR; Nag A; Drinan SD; Wollison BM; Bass AJ; Giordano S
Cancer Res; 2019 Nov; 79(22):5884-5896. PubMed ID: 31585941
[TBL] [Abstract][Full Text] [Related]
40. Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.
Sun Y; Yu W; Guan W; Cai L; Qiao M; Zheng L; Jiang R; Wang R; Wang L
Cancer Manag Res; 2019; 11():6397-6410. PubMed ID: 31372044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
